Annual Equity. For each fiscal year of the Company that you are employed during the Term (other than fiscal year 2012), you will be eligible for an annual equity grant based on achievement of objectives established by the Committee, and on such other terms established by the Committee. In accordance with the policies and practices of the Company, some or all of such annual equity grant may be in the form of restricted stock units, performance share units, or other equity that is an economic equivalent to an option award. Such equivalency will be determined by the Company in its sole discretion. Initial Equity: The Company shall grant to you, on January 27, 2012, or, if later, your start date (the “Date of Grant”), a non-statutory stock option to purchase 150,000 shares of the common stock of the Company (the “Option”). The Option will have an exercise price equal to the closing sale price of a share of common stock on the Date of Grant, will be subject to four-year ratable vesting (except for such earlier vesting as otherwise provided in the Management Agreement or in the applicable grant agreement) and will have a term of seven years. The Company also shall grant to you, on the Date of Grant, 50,000 Restricted Stock Units (“RSUs”). The RSUs also will be subject to four-year ratable vesting (except for such earlier vesting as otherwise provided in the Management Agreement or in the applicable grant agreement). The Option and RSUs will be granted under and subject to the terms of the Company’s 1992 Long-Term Incentive Plan (except for Article 13) and in the form of the equity award agreements attached hereto. Any vested RSUs will be settled in the form of shares of common stock delivered to you within fifteen (15) days of vesting. In addition, the Company confirms that the termination of the 1992 Long-Term Incentive Plan will not affect the Option and RSU grants made thereunder. In addition, the Company shall grant to you, on the Date of Grant, a Performance Share Unit (“PSU”) award with a target value of 50,000 shares of common stock of the Company and a maximum value of 100,000 shares (subject to appropriate adjustment for corporate events). Depending on the Company’s satisfaction of certain performance metrics during the Company’s 2012 fiscal year, as identified in your PSU award agreement, the actual number of units that will be deemed earned may range from zero up to 100,000 (subject to appropriate adjustment for corporate events). The amount of earned shares will be...
Annual Equity. Awards The Executive shall be granted or allocated restricted stock units (or such other securities/instruments that the Committee deems appropriate) (“Awarded Securities”) as part of the long-term incentive compensation approved annually by the Committee (the “Annual Equity Award”). Each Annual Equity Award shall be granted pursuant to the terms and conditions of the Partnership’s 2014 Stock Incentive Plan, as may be amended, restated or supplemented from time to time (the “Plan”), and the form(s) of Annual Equity Award thereunder shall be no less favorable to the Executive than the Annual Equity Award to other senior executives of the Company. The Annual Equity Award in respect of any fiscal year shall be granted no later than seven (7) calendar days following the completion of the audit of the Company’s financial statements for the fiscal year preceding the year the Awarded Securities are granted or allocated (the “Grant Year”) (and in any event no later than the date any Annual Equity Award or other equity-based compensation is granted to other senior executives of the Company in respect of such fiscal year). The number of Awarded Securities that comprise an Annual Equity Award shall be no less than the number equal to the Annual Equity Award Cash Equivalent (defined below) divided by the average closing price of the Company’s common stock on the primary exchange on which it trades (the “Closing Price”) for the final fifteen (15) trading days of the Grant Year. The “Annual Equity Award Cash Equivalent” shall be an amount not less than two times the salary compensation received by the Executive from the Company in the Grant Year (“Salary”) with such amount constituting target achievement or no greater than three times Salary with such amount constituting maximum achievement. The actual number of Awarded Securities shall be determined based upon the Company’s total shareholder return goals, certain corporate strategic goals, and other metrics or goals as established by the Committee in consultation with the Executive not later than the 90th day of the Grant Year. Awarded Securities issued in respect of any Grant Year shall be subject to a three-year post-issuance service-based vesting schedule, with one-third (1/3 or 33%) of such Awarded Securities vesting on each of the first three annual anniversaries of the first day of the fiscal year following the fiscal year in respect of which such Awarded Securities are actually issued provided the Executive rema...
Annual Equity. The Executive will be eligible to participate in the annual equity plan (the “Annual Equity”) and be eligible to receive an Annual Equity with a target value of Seventy-Five percent (75%) of his Annual Base Salary upon one hundred percent (100%) achievement of annual objectives, beginning with the Company’s 2018 fiscal year. For subsequent years, the Annual Equity target as a percentage of then-current Annual Base Salary, may be adjusted, but may not be less than Seventy-Five percent (75%) of the Executive’s then-current Annual Base Salary. The equity, if any, will be determined by the Board based upon the Company’s achievement of financial performance goals and other objectives, as determined by the Compensation Committee for each fiscal year of the Company. Executive shall be eligible to receive annual equity awards in accordance with equity compensation arrangements established by the Compensation Committee. The grants shall have such terms as are determined by the Compensation Committee in accordance with the current stock plan in place at time of grant.
Annual Equity. 7.6.1 You will be eligible for annual equity awards as determined by the Compensation Committee of the Board of Directors of lululemon athletica inc. in its sole discretion as notified to You from time to time. Your eligibility will at all times be subject to and conditional upon the rules of any annual equity awards. The potential equity awards currently consist of stock options, restricted share units and performance share units. The Company reserves the right to vary or terminate (with or without any replacement awards) any annual equity awards in place from time to time.
Annual Equity. Executive will be eligible for consideration for future annual stock-based awards in accordance with UnitedHealth Group’s governance policy and guideline amounts authorized by UnitedHealth Group’s Compensation and Human Resources Committee. For calendar year 2022, management will recommend that Executive be awarded an annual equity grant with a target value of $4,500,000. The actual grant value of any such future equity grants and the related terms are at the sole discretion of UnitedHealth Group and will be subject to the terms of the UnitedHealth Group 2020 Stock Incentive Plan (or a successor plan), including certain restrictive covenants.
Annual Equity. Rights Prior to January 15, 2006 Executive shall receive a grant of stock appreciation rights or by mutual agreement of the Company and the Executive, stock options for 100,000 shares of Company common stock at an exercise price per share equal to Fair Market Value (as defined in the Plan) on the date of grant (the “Annual Award”). Subject to Executive’s continued employment with the Company, such Annual Award will vest in equal installments on each of the first three anniversaries of the date of grant, and will become fully vested upon the occurrence of a Change in Control of the Company as defined in the Plan and the award certificate. Other terms and conditions of the Annual Award shall be as set forth herein, in the Plan and the award certificate. If the Company should, prior to any Annual Award grant, be involved in any merger, reorganization, stock split or spinoff or other similar event, the number of shares subject to the Annual Award yet to be granted, as provided above, shall be adjusted on a pro rata basis.
Annual Equity. The Executive will be eligible to participate in the annual equity plan (the “Annual Equity”) and be eligible to receive an Annual Equity with a target value of Seventy-Five percent (75%) of his Annual Base Salary upon one hundred percent (100%) achievement of annual objectives. The Annual Equity target as a percentage of then-current Annual Base Salary, may be adjusted, but may not be less than Seventy-Five percent (75%) of the Executive’s then-current Annual Base Salary. The equity, if any, will be determined by the Board based upon the Company’s achievement of financial performance goals and other objectives, as determined by the Compensation Committee for each fiscal year of the Company. Executive shall be eligible to receive annual equity awards in accordance with equity compensation arrangements established by the Compensation Committee. The grants shall have such terms as are determined by the Compensation Committee in accordance with the current stock plan in place at time of grant.
Annual Equity. Executive shall continue to receive an annual equity grant based on terms and conditions that are comparable to those applicable to grants made to other senior executives of the Company, including achievement of personal or Company objectives established by the Board, and on such other terms applicable to other executives as are established by the Board in its reasonable discretion. For each year during the Term, the value of Executive’s annual equity grant is expected to be $800,000.00 (as measured on the date of grant and based on the Board’s assessment of the Company’s performance against Executive’s and the Company’s performance objectives). In accordance with the policies and practices of the Company, some or all of any annual equity grant may be in the form of restricted stock, stock options, stock units or other equity that is an economic equivalent to an option or a restricted stock award. Such equivalency will be determined by the Board in its reasonable discretion.
Annual Equity. Beginning in February 2015 and continuing thereafter on an annual basis during the Term, Executive shall receive an annual equity grant based on terms and conditions that are comparable to those applicable to grants made to other senior executives of the Company, including achievement of personal or Company objectives established by the Board, and on such other terms applicable to other executives as are established by the Board in its reasonable discretion. For each year during the Term, the value of Executive’s annual equity grant is expected to be $800,000.00 (as measured on the date of grant and based on the Board’s assessment of the Company’s performance against Executive’s and the Company’s performance objectives). In accordance with the policies and practices of the Company, some or all of any annual equity grant may be in the form of restricted stock, stock options, stock units or other equity that is an economic equivalent to an option or a restricted stock award. Such equivalency will be determined by the Board in its reasonable discretion.
Annual Equity. Employee shall be eligible to participate in the annual equity incentive program of Parent and receive grants of equity or equity-based awards which may be options (each, an “Equity Award”), with vesting over four years, subject to the terms and conditions of Parent’s Omnibus Equity Incentive Plan (the “EIP”) and Parent’s standard form of award agreement. Employee’s Equity Award for the 2022 calendar year shall be a number of options to purchase Parent’s common stock with an equivalent value of $378,000 on the date of grant. During the Term for 2023 and annually thereafter, Employee’s Equity Award shall have a target value of (150% of Base Compensation) $630,000 as of the date of grant and it is intended that such award be made in options.
